Board Meetings for AUROPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| AUROPHARMA | Aurobindo Pharma Limited | 09 Feb 2016 | Results | to consider, inter alia, the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2015. | |
| AUROPHARMA | Aurobindo Pharma Limited | 09 Feb 2016 | Results/Dividend | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on February 9, 2016, to consider, inter alia, the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2015. The Company has now informed the Exchange that the Board will also consider the proposal of payment of Third Interim Dividend for the year 2015-16. | |
| AUROPHARMA | Aurobindo Pharma Limited | 06 Nov 2015 | Results | To consider inter alia, the Un-Audited Financial Results of the Company for the quarter and half year ended September 30,2015. | |
| AUROPHARMA | Aurobindo Pharma Limited | 06 Nov 2015 | Results/Dividend | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held November 6, 2015 to consider inter alia, the Un-Audited Financial Results of the Company for the quarter and half year ended September 30,2015.The Company has now informed the Exchange that the meeting of the Board of Directors will also consider the proposal of payment of Second Interim Dividend for the year 2015-16 (Purpose Revised). | |
| AUROPHARMA | Aurobindo Pharma Limited | 12 Aug 2015 | Results | To consider, inter alia, the Un-Audited Financial Results of the Company for the quarter ended June 30, 2015. | |
| AUROPHARMA | Aurobindo Pharma Limited | 12 Aug 2015 | Results/Dividend | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held on August 12, 2015, to consider, inter alia, the Un-Audited Financial Results of the Company for the quarter ended June 30, 2015.The Company has now informed the Exchange that the meeting of the Board of Directors of the Company schedule to be held on August 12, 2015, will also consider the proposal of payment of Interim Dividend for the year 2015-16. (Purpose Revised) | |
| AUROPHARMA | Aurobindo Pharma Limited | 28 May 2015 | Results/Dividend | Inter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2015. Further at the said Board meeting the Board will also consider payment of Dividend, if any, for the year 2014-15. | |
| AUROPHARMA | Aurobindo Pharma Limited | 04 Feb 2015 | Results/Dividend | To consider inter alia, the Un-Audited Financial Results of the Company for the quarter ended December 31, 2014. Further, the Board will also consider 2nd interim Dividend, if any, for the financial year 2014-15. | - |
| AUROPHARMA | Aurobindo Pharma Limited | 25 Nov 2014 | Issue of Securities | to inter alia consider raising of funds through issue of securities. | - |
| AUROPHARMA | Aurobindo Pharma Limited | 06 Nov 2014 | Results | To consider inter alia, the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2014. | - |
| AUROPHARMA | Aurobindo Pharma Limited | 07 Aug 2014 | Results | to consider, inter alia, the Un-Audited Financial Results of the Company for the quarter ended June 30, 2014. | - |
| AUROPHARMA | Aurobindo Pharma Limited | 30 May 2014 | Results/Dividend | Inter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2014. Further at the said Board meeting the Board will also consider recommendation of Final Dividend, if any, for the year 2013-14. | |
| AUROPHARMA | Aurobindo Pharma Limited | 06 Feb 2014 | Results | To consider inter alia, the Un-Audited Financial Results of the Company for the quarter ended December 31, 2013. | - |
| AUROPHARMA | Aurobindo Pharma Limited | 07 Nov 2013 | Results | To consider inter alia, the Un-Audited Financial Results of the Company for the quarter and half year ended September 30,2013. | - |
| AUROPHARMA | Aurobindo Pharma Limited | 07 Nov 2013 | Results/Dividend | The company had informed the Exchange that the meeting of the Board of Directors of the Company is scheduled to be held on November 07, 2013 to consider inter alia, the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2013. The company has now informed the Exchange that, in the aforesaid meeting, the Board will also consider the proposal of payment of Interim Dividend for the year 2013-14. (Purpose Revised). | - |